Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

18.28
+0.35001.95%
Post-market: 18.25-0.0300-0.16%19:16 EST
Volume:296.87K
Turnover:5.37M
Market Cap:490.22M
PE:-70.64
High:18.53
Open:17.97
Low:17.72
Close:17.93
52wk High:23.00
52wk Low:11.09
Shares:26.82M
Float Shares:18.14M
Volume Ratio:1.20
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2588
EPS(LYR):-0.1476
ROE:-34.17%
ROA:1.25%
PB:21.20
PE(LYR):-123.82

Loading ...

Feb 02, 2026

Major Issues Report

Form 8-K - Current report
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 19, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities